Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway
Open Access
- 28 February 2019
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 10 (1) , 70
Abstract
The objective of this study is to determine if exuberant sympathetic nerve activity is involved in muscle satellite cell differentiation and myoblast fusion. By using immunoassaying and western blot analyses, we found that β1 and β2-adrenergic receptors (AdR) were expressed in C2C12 cells. The differentiated satellite cells exhibited an increased expression of β2-AdR, as compared with the proliferating cells. Continuous exposure of isoprenaline (ISO), a β-AdR agonist, delayed C2C12 cell differentiation, and myoblast fusion in time- and dose-dependent manner. ISO also increased short myotube numbers while decreasing long myotube numbers, consistent with the greater reduction in MyHC1, MyHC2a, and MyHC2x expression. Moreover, continuous exposure of ISO gradually decreased the ratio of PKA RI/RII, and PKA RI activator efficiently reversed the ISO effect on C2C12 cell differentiation and myoblast fusion while PKA inhibitor H-89 deteriorated the effects. Continuous single-dose ISO increased β1-AdR expression in C2C12 cells. More importantly, the cells showed enhanced phospho-ERK1/2 levels, resulting in increasing phospho-β2-AdR levels while decreasing β2-AdR levels, and the specific effects could be abolished by ERK1/2 inhibitor. Furthermore, continuous exposure of ISO induced FOXO1 nuclear translocation and increased the levels of FOXO1 in nuclear extracts while reducing pAKT, p-p38MAPK, and pFOXO1 levels. Conversely, blockade of ERK1/2 signaling partially abrogated ISO effects on AKT, p38MAPK, and FOXO1signaling, which partially restored C2C12 cell differentiation and myoblast fusion, leading to an increase in the numbers of medium myotube along with the increased expression of MyHC1 and MyHC2a. Continuous exposure of ISO impedes satellite cell differentiation and myoblast fusion, at least in part, through PKA-ERK1/2-FOXO1 signaling pathways, which were associated with the reduced β2-AdR and increased β1-AdR levels.Keywords
Funding Information
- National Natural Science Foundation of China (81670272, 81170095)
- Natural Science Foundation of Hubei Province (2018ACA162, 2016CFA027)
- Hubei University of Medicine Innovation Team (FDFR201601)
This publication has 41 references indexed in Scilit:
- Adrenergic Nervous System in Heart FailureCirculation Research, 2013
- TGF-β-activated Kinase 1 (TAK1) and Apoptosis Signal-regulating Kinase 1 (ASK1) Interact with the Promyogenic Receptor Cdo to Promote Myogenic Differentiation via Activation of p38MAPK PathwayJournal of Biological Chemistry, 2012
- Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1Neuropathology and Applied Neurobiology, 2009
- Mechanism regulating proasthmatic effects of prolonged homologous β2-adrenergic receptor desensitization in airway smooth muscleAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise trainingJournal of Applied Physiology, 2009
- Prolonged heterologous β2-adrenoceptor desensitization promotes proasthmatic airway smooth muscle function via PKA/ERK1/2-mediated phosphodiesterase-4 inductionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- A Foxo/Notch pathway controls myogenic differentiation and fiber type specificationJournal of Clinical Investigation, 2007
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005
- β2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscleJournal of Applied Physiology, 2005
- Desensitization of the isolated .beta.2-adrenergic receptor by .beta.-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanismsBiochemistry, 1992